Phase II Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced or Metastatic Gastrointestinal Cancers
Summary
The purpose of this study is compare different doses of capecitabine to see if one is better than the other in terms of efficacy and toxicity.
General Information
NCT#: NCT02595320
Study ID: 2015-X7-7-LQT
Trial Phase: Phase II
Trial Sponsor: University of Kansas Medical Center
Therapies Used in This Trial: Capecitabine